Navigation Links
Varian, Inc. Delivers a Productivity Increase of Up to 100% With Its 710-ES Series ICP-OES

PALO ALTO, Calif., Oct. 12 /PRNewswire-FirstCall/ -- Varian, Inc. (Nasdaq: VARI) announced today a series of productivity enhancements for its 710-ES Series of ICP-OES (Inductively Coupled Plasma - Optical Emission Spectrometer) instruments. The enhancements comprise hardware, software and accessory options available both on new instruments as well as on upgrades to existing equipment. They enable users to reduce sample analysis times by up to 50% and lower the cost of each analysis.

For routine analytical laboratories, sample throughput is key to profitability. The 710-ES series is designed for laboratories handling low to moderate numbers of samples in a variety of application areas requiring elemental analysis. Users also include educational institutes and industries that need to comply with environmental protection laws and regulations such as toy safety and the European Union's directives on the Restriction of the use of Hazardous Substances (RoHS) and on Waste Electrical and Electronic Equipment (WEEE).

By combining the Varian 710-ES Series ICP-OES with Varian's new ICP Expert(TM) II software (version 1.1.3), users can reduce sample analysis times by up to 50% lowering the cost per analysis. These productivity benefits result from the high-efficiency signal processing used in the new ICP Expert II software. Existing users can simply upgrade their software to take advantage of all these benefits.

Varian offers new hardware and accessory options for the 710-ES Series ICP-OES to further enhance productivity and improve day-to-day reproducibility. Mass flow control (MFC) of the nebulizer gas is offered as an option for new instruments and can be retrofitted to existing systems (with service installation). The MFC provides better long-term stability, reducing the need for recalibration, so users can run more samples every day. Because the nebulizer flow is automatically set by the computer every time methods are run, the MFC also simplifies instrument set-up and enhances reproducibility.

The 710-ES Series ICP-OES are also compatible with Varian's Productivity Package, which allows use of the fully automated Switching Valve System (SVS). By coupling the SVS with the 710-ES series, users can achieve a further improvement in productivity of up to 20% and reduce argon consumption by up to 20%.

"These productivity enhancements enable our customers to achieve even more with our 710-ES ICP-OES spectrometers," said Martin O'Donoghue, Senior Vice President, Scientific Instruments, Varian, Inc. "We've enhanced our product line to deliver more value to our customers, strengthening our company's global position in elemental analysis."

For more information about Varian's ICP-OES product portfolio, please visit:

About Varian, Inc.:

Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science and industrial applications. The company provides complete solutions, including instruments, vacuum products, laboratory consumable supplies, software, training and support through its global distribution and support systems. Varian, Inc. employs approximately 3,500 people worldwide and operates manufacturing facilities in North America, Europe and Asia Pacific. Varian, Inc. had fiscal year 2008 sales of $1 billion, and its common stock is traded on the NASDAQ Global Select Market under the symbol, "VARI." Further information is available on the company's Web site:

    For more information, contact:
    Public Relations
    Varian, Inc.
    (925) 942-4703

SOURCE Varian, Inc.

SOURCE Varian, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. 96-Well Filtration Plate From Varian, Inc. Improves Sensitivity and Precision for Trace Bio-Analysis by LC/MS
2. Ethicon Endo-Surgery Launches New Echelon Flex(TM) Endopath(R) Stapler That Delivers Echelon(TM) Compression, Now With Natural Articulation
3. Hoviones TwinCaps(R) Inhaler Delivers Successfully in Phase III Clinical Trials for Influenza
4. Vtech(R) Delivers Todays Hottest Trends to Tech-Savvy Kids
5. VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers
6. VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma
7. PARIs eFlow Delivers Alnylam RNAi Therapeutic in Phase II Study
8. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
9. InVitria Showcases Cell Culture Productivity Enhancers at BioProcess International
10. Stereotaxis Receives Commitment to Increase and Extend Its Credit Facility With Silicon Valley Bank
11. West Increases Quarterly Dividend to $0.16
Post Your Comments:
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
(Date:11/25/2015)... On Tuesday, November 24, 2015, the ... Wright Medical Technology, Inc. for product liability and ... implant device, awarded $11 million in favor of ... and three days of deliberations, the jury found ... designed and unreasonably dangerous, and that Wright Medical ...
(Date:11/25/2015)... -- Allergan plc (NYSE: AGN ) today announced that ... York State Attorney General,s Office to end the ... statutes with the Attorney General over the decision of Forest ... selling the now generic version of memantine immediate release tablets.  ... released its counterclaims against New York , ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... the way that they are handling security in light of the recent terrorist attacks ... in an attempt to stop an attack from reaching U.S. soil. Especially around special ...
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss ... to treat it. Surviving Mesothelioma has just posted the findings on the website. ... Zurich analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy followed ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When ... said an inventor from Hillside, N.J. "Many people catch diseases simply from sitting ... individuals will always be protected from germs." , He developed the patent-pending QUDRATECS ...
(Date:11/27/2015)... ... ... The print component of “Supporting Our Caregivers” is distributed ... Minneapolis, South Florida, with a circulation of approximately 250,000 copies and an estimated ... media strategy and across a network of top news sites and partner media ...
(Date:11/27/2015)... ... ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% of its ... 3.7 billion people under the age of 50 – or 67% of the population - ... estimates of HSV-1 infection . , "The data shocks us highly!" said Michelle Li, ...
Breaking Medicine News(10 mins):